U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07459283) titled 'The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors' on March 04.
Brief Summary: This study is a prospective, single-arm, open-label, dose-escalation study. A total of 4 dose groups were pre-defined in this study. The drug was administered once every 6 weeks.The drug would be administered for 1 to 4 cycles. The dosing schedule and dose could also be adjusted according to the patient's condition. After each dose group completed the enrollment and DLT observation, based on the participant's safety tolerance, radiation dosimetry, and preliminary efficacy evaluation results, it was decided whether...